These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8450893)
1. [Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo]. Pfaffenrath V; Diener HC; Isler H; Meyer C; Scholz E; Taneri Z; Wessely P; Zaiser-Kaschel H; Haase W; Fischer W Nervenarzt; 1993 Feb; 64(2):114-20. PubMed ID: 8450893 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Pfaffenrath V; Diener HC; Isler H; Meyer C; Scholz E; Taneri Z; Wessely P; Zaiser-Kaschel H; Haase W; Fischer W Cephalalgia; 1994 Apr; 14(2):149-55. PubMed ID: 8062354 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
4. Spinal manipulation vs. amitriptyline for the treatment of chronic tension-type headaches: a randomized clinical trial. Boline PD; Kassak K; Bronfort G; Nelson C; Anderson AV J Manipulative Physiol Ther; 1995; 18(3):148-54. PubMed ID: 7790794 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM; Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD; Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
9. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled clinical trial of chiropractic and medical prophylactic treatment of adults with tension-type headache: results from a stopped trial. Vernon H; Jansz G; Goldsmith CH; McDermaid C J Manipulative Physiol Ther; 2009 Jun; 32(5):344-51. PubMed ID: 19539116 [TBL] [Abstract][Full Text] [Related]
11. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Kivitz A; Ma C; Ahdieh H; Galer BS Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450 [TBL] [Abstract][Full Text] [Related]
12. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial. Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406 [TBL] [Abstract][Full Text] [Related]
13. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Couch JR; Headache; 2011 Jan; 51(1):33-51. PubMed ID: 21070231 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache. Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050 [TBL] [Abstract][Full Text] [Related]
16. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474 [TBL] [Abstract][Full Text] [Related]
17. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS). Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ; Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. Lizogub VG; Riley DS; Heger M Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909 [TBL] [Abstract][Full Text] [Related]
20. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Sorge J; Sittl R Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]